APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,500 | -99.9% | 100,000 | -87.7% | 0.00% | -99.9% |
| Q2 2023 | $73,976,570 | +102.0% | 812,037 | +46.2% | 2.14% | +97.9% |
| Q1 2023 | $36,630,490 | +46.4% | 555,344 | +51.6% | 1.08% | +49.0% |
| Q3 2022 | $25,025,000 | +72.2% | 366,400 | +14.0% | 0.73% | +59.6% |
| Q2 2022 | $14,529,000 | -80.7% | 321,300 | -78.3% | 0.46% | -69.8% |
| Q1 2022 | $75,285,000 | -45.2% | 1,481,700 | -49.0% | 1.51% | +42.4% |
| Q4 2021 | $137,272,000 | +577.2% | 2,903,400 | +372.1% | 1.06% | +260.2% |
| Q3 2021 | $20,270,000 | -75.7% | 615,000 | -53.5% | 0.29% | -45.9% |
| Q2 2021 | $83,570,000 | +22304.8% | 1,322,324 | +11481.0% | 0.54% | +8950.0% |
| Q2 2020 | $373,000 | +14.1% | 11,418 | 0.0% | 0.01% | -33.3% |
| Q1 2020 | $327,000 | – | 11,418 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |